Mårtensson, T <br/><br/>
Increased risk of gastrointestinal acute GVHD following the addition of melphalan to busulfan/cyclophosphamide conditioning.  [electronic resource] 

 -  Pediatric transplantation  May 2013 
 - 285-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1399-3046 
<br/><br/><label>Standard No.: </label>10.1111/petr.12061  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Busulfan--administration & dosage<br/>Child<br/>Child, Preschool<br/>Cyclophosphamide--adverse effects<br/>Female<br/>Gastrointestinal Tract--drug effects<br/>Graft vs Host Disease--diagnosis<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Infant<br/>Leukemia, Myelomonocytic, Acute--therapy<br/>Male<br/>Melphalan--administration & dosage<br/>Myelodysplastic Syndromes--therapy<br/>Retrospective Studies<br/>Risk Factors<br/>Transplantation Conditioning--adverse effects<br/>Treatment Outcome